1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Immunosuppressive Treatment: new trials by email Literature Review of Immunosuppressive Treatment trials Research Report on Immunosuppressive Treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia Dose-attenuated IST and Hetrombopag - Sever Aplastic Anaemia, Elderly (People Aged 65 or More) | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 65 | 2025-02-01 | 2025-06-08 |
hetrombopag (1)
Institute of Hematology & Blood Diseases Hospital, China (1)
China (1)
Jun Shi, PhD (1)